ArticleBiochemistry and biophysics reports2026
Exploring the impact of hAMSCs secretome on Panc1 cells via TNF-α/NF-κB (p50/p65)/Caspase 3 signaling pathways: An
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The second most prevalent cause of mortality worldwide is cancer. Pancreatic cancer, known as the "king of cancers" due to its unfavorable prognosis and absence of symptoms, is among the fatal types of cancer. Despite the availability of various cancer therapy options, current strategies are often ineffective. Therefore, there is a constant need to explore novel platforms with low side effects and high efficacy. The application of stem cells or their derivatives in treating diseases including cancer, has become well-established. This study, focuses on investigating the effects of the secretome of human mesenchymal stem cells (hAMSCs) on Panc1 pancreatic cancer cells through the tumor necrosis factor-alpha (TNF-α)/nuclear factor-κB (NF-κB)/Caspase 3 signaling pathways. A co-culture system using 6-well plates transwell was utilized for this purpose. After 72 h, cell death in hAMSCs-treated Panc1 cells was analyzed through the TNF-α/NF-κB (p50/p65)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.